List of works - Anupom Borah

1-Methyl-4-Phenylpyridinium-Induced Death of Differentiated SH-SY5Y Neurons Is Potentiated by Cholesterol

scientific article published on 30 October 2017

A Friend or Foe: Calcineurin across the Gamut of Neurological Disorders

scientific article published on 27 June 2018

A highly reproducible mice model of chronic kidney disease: Evidences of behavioural abnormalities and blood-brain barrier disruption

scientific article published in August 2016

Accumulation of Cholesterol and Homocysteine in the Nigrostriatal Pathway of Brain Contributes to the Dopaminergic Neurodegeneration in Mice

scientific article published on 01 August 2018

Activation of NMDA receptor by elevated homocysteine in chronic liver disease contributes to encephalopathy

scientific article published on 3 April 2015

Attenuation of Aluminum Chloride-Induced Neuroinflammation and Caspase Activation Through the AKT/GSK-3β Pathway by Hesperidin in Wistar Rats.

scientific article published on 23 April 2018

Cholesterol - A putative endogenous contributor towards Parkinson's disease.

scientific article published on 29 July 2015

Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.

scientific article

Cholesterol in Pancreatic β-Cell Death and Dysfunction: Underlying Mechanisms and Pathological Implications

scientific article published on 18 December 2015

Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson's disease.

scientific article published on 26 February 2016

Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease

scientific article published on 10 April 2013

Current Progress and Biotechnological Applications of Microbial Keratinases

scientific article published in 2023

Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment.

scientific article

Garcinol, a multifaceted sword for the treatment of Parkinson's disease

scientific article published on 12 April 2019

Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell

scientific article published on 26 October 2017

Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice.

scientific article published on 20 December 2017

Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson's disease

scientific article published on 3 February 2017

Inflammasomes in stroke: a triggering role for acid-sensing ion channels

scientific article published on 19 June 2018

Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer neuroprotection in cerebral ischemia: an in silico evaluation of the hypothesis

scientific article published on 13 October 2014

L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patients

scientific article published on 27 May 2012

L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra

scientific article published on 6 June 2016

L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation

scientific article published on 18 November 2009

L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room.

scientific article

Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats

scientific article published on 13 October 2007

Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents

scientific article published in October 2009

Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease.

scientific article published on 11 November 2017

Mitochondrial Dysfunction in Stroke: Implications of Stem Cell Therapy

scientific article published on 20 June 2018

Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics

scientific article published on 27 May 2019

Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action.

scientific article published on 14 October 2013

Noncoding RNAs in ischemic stroke: time to translate

scientific article published on 23 April 2018

Novel Targets for Parkinson's Disease: Addressing Different Therapeutic Paradigms and Conundrums

scientific article published on 11 July 2018

Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease.

scientific article published on 11 October 2016

Piroxicam confer neuroprotection in Cerebral Ischemia by inhibiting Cyclooxygenases, Acid- Sensing Ion Channel-1a and Aquaporin-4: an in silico comparison with Aspirin and Nimesulide.

scientific article published on 30 April 2015

Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug.

scientific article published on 13 October 2014

Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism

scientific article published on 12 May 2010

Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats

scientific article published on 4 May 2009

Stroke Management: An Emerging Role of Nanotechnology

scientific article published on 28 August 2017

The potential physiological crosstalk and interrelationship between two sovereign endogenous amines, melatonin and homocysteine

scientific article published on 14 August 2015

Therapeutic spectrum of interferon-β in ischemic stroke

scientific article published on 15 October 2018

Trigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke

scientific article published on 07 November 2018

α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease

scientific article published on June 2016

β-phenethylamine--a phenylalanine derivative in brain--contributes to oxidative stress by inhibiting mitochondrial complexes and DT-diaphorase: an in silico study.

scientific article published on 3 May 2013

List of works by Anupom Borah

1-Methyl-4-Phenylpyridinium-Induced Death of Differentiated SH-SY5Y Neurons Is Potentiated by Cholesterol

A Friend or Foe: Calcineurin across the Gamut of Neurological Disorders

A highly reproducible mice model of chronic kidney disease: Evidences of behavioural abnormalities and blood-brain barrier disruption

Accumulation of Cholesterol and Homocysteine in the Nigrostriatal Pathway of Brain Contributes to the Dopaminergic Neurodegeneration in Mice

Activation of NMDA receptor by elevated homocysteine in chronic liver disease contributes to encephalopathy

Attenuation of Aluminum Chloride-Induced Neuroinflammation and Caspase Activation Through the AKT/GSK-3β Pathway by Hesperidin in Wistar Rats.

Cholesterol - A putative endogenous contributor towards Parkinson's disease.

Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.

Cholesterol in Pancreatic β-Cell Death and Dysfunction: Underlying Mechanisms and Pathological Implications

Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson's disease.

Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease

Current Progress and Biotechnological Applications of Microbial Keratinases

Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment.

Garcinol, a multifaceted sword for the treatment of Parkinson's disease

Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell

Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice.

Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson's disease

Inflammasomes in stroke: a triggering role for acid-sensing ion channels

Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer neuroprotection in cerebral ischemia: an in silico evaluation of the hypothesis

L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patients

L-DOPA treatment in MPTP-mouse model of Parkinson's disease potentiates homocysteine accumulation in substantia nigra

L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation

L-DOPA-induced hyperhomocysteinemia in Parkinson's disease: Elephant in the room.

Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats

Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents

Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease.

Mitochondrial Dysfunction in Stroke: Implications of Stem Cell Therapy

Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics

Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action.

Noncoding RNAs in ischemic stroke: time to translate

Novel Targets for Parkinson's Disease: Addressing Different Therapeutic Paradigms and Conundrums

Oxidative stress and mitochondrial dysfunction are the underlying events of dopaminergic neurodegeneration in homocysteine rat model of Parkinson's disease.

Piroxicam confer neuroprotection in Cerebral Ischemia by inhibiting Cyclooxygenases, Acid- Sensing Ion Channel-1a and Aquaporin-4: an in silico comparison with Aspirin and Nimesulide.

Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug.

Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism

Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats

Stroke Management: An Emerging Role of Nanotechnology

The potential physiological crosstalk and interrelationship between two sovereign endogenous amines, melatonin and homocysteine

Therapeutic spectrum of interferon-β in ischemic stroke

Trigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic stroke

α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease

β-phenethylamine--a phenylalanine derivative in brain--contributes to oxidative stress by inhibiting mitochondrial complexes and DT-diaphorase: an in silico study.